Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
22.86
+0.09 (0.40%)
Feb 3, 2026, 9:55 AM CST
SHE:002262 Market Cap
SHE:002262 has a market cap or net worth of 23.13 billion as of February 2, 2026. Its market cap has decreased by -3.23% in one year.
Market Cap
23.13B
Enterprise Value
19.18B
Revenue
6.02B
Ranking
n/a
PE Ratio
18.81
Stock Price
22.86
Market Cap Chart
Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 23.13B, an increase of 1,729.14%. That is a compound annual growth rate of 18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 24.00B | -2.07% |
| Dec 31, 2025 | 24.51B | -0.94% |
| Dec 31, 2024 | 24.74B | -9.45% |
| Dec 29, 2023 | 27.33B | 10.47% |
| Dec 30, 2022 | 24.74B | 56.87% |
| Dec 31, 2021 | 15.77B | -2.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 28.41B |
| Chengdu Kanghong Pharmaceutical Group | 27.04B |
| Dizal (Jiangsu) Pharmaceutical | 26.45B |
| Kangmei Pharmaceutical | 26.27B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 24.84B |
| Hubei Jumpcan Pharmaceutical | 24.01B |
| Jilin Aodong Pharmaceutical Group | 23.96B |
| Zhejiang Huahai Pharmaceutical | 23.43B |